Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 353 (9153), 611-616
- https://doi.org/10.1016/s0140-6736(98)05012-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- ACE Inhibition Preserves Renal Function Better thanbT-blockade in the Treatment of Essential HypertensionBlood Pressure, 1995
- The 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH MeetingBlood Pressure, 1993
- Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.Hypertension, 1992
- Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.BMJ, 1992
- Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trialsBlood Pressure, 1992
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- Left Ventricular HypertrophyDrugs, 1988
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986